The value and inadequacy of tumor mutation burden on efficacy of immune checkpoint inhibitors in head and neck cancers

MeSH terms

• Biomarkers, Tumor
• Head and Neck Neoplasms* / drug therapy
• Head and Neck Neoplasms* / genetics
• Humans
• Immune Checkpoint Inhibitors* / pharmacology
• Immunotherapy
• Mutation*
• Squamous Cell Carcinoma of Head and Neck* / drug therapy
• Squamous Cell Carcinoma of Head and Neck* / genetics